The actions of angiotensin II on the isolated portal vein of the rat.
D000109:Acetylcholine / Q000494:pharmacology; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D009994:Osmolar Concentration; D010646:Phentolamine / Q000037:antagonists & inhibitors; D011169:Portal Vein / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012756:Sheep; D012965:Sodium Chloride / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000804:Angiotensin II; D012701:Serotonin; D012965:Sodium Chloride; D013395:Sucrose; D006632:Histamine; D014508:Urea; D000109:Acetylcholine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine